Whole-genome Sequencing of an Aggressive BRAF Wild-type Papillary Thyroid Cancer Identified EML4–ALK Translocation as a Therapeutic Target (Q58049946)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

main subject

whole genome sequencing

1 reference

inferred from title

papillary thyroid cancer

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Meraj Aziz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Richard Rosenberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Michael J Demeure

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Steven D Gurley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

John D Carpten

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

1 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

published in

World Journal of Surgery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

1296-1305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00268-014-2485-3

10 March 2020

exact match

0 references

cites work

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Papillary thyroid carcinoma tall cell variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Exome sequencing identifies GRIN2A as frequently mutated in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Genome sequencing identifies a basis for everolimus sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Rearranged anaplastic lymphoma kinase (ALK) gene in adult-onset papillary thyroid cancer amongst atomic bomb survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

An immunohistochemical study of p16(INK4a) expression in multistep thyroid tumourigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2485-3

The many appearances of papillary carcinoma of the thyroid

21 January 2018

1 reference

12 December 2020

DNA hypermethylation status of multiple genes in papillary thyroid carcinomas

1 reference

12 December 2020

Therapeutic effect of tamoxifen related to estrogen receptor level

1 reference

12 December 2020

Mutational analysis of the GNA11, MMP27, FGD1, TRRAP and GRM3 genes in thyroid cancer

1 reference

12 December 2020

10.1007/S00268-014-2485-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633422%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference